The London Health Sciences Foundation (LHSF) just got a big boost - $5 million in funding for breast cancer research.
The money will go towards the Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit (TBCRU) at the London Health Sciences Centre's Regional Cancer Program.
A partnership between the LHSF and the Breast Cancer Society of Canada began in 1998 - when it funded the creation of the unit - and the most recent donation brings the support for breast cancer research at LHSF to over $10 million.
Marsha Davidson, executive director of the Breast Cancer Society of Canada, said in a statement “This gift represents the largest funding commitment ever made in our 23-year history. We are proud to fund our partners...to continue the TBCRU’s world-renowned, life-saving research.”
The unit conducts research that is designed to enhance and advance cancer treatment by "taking observations and questions from the bedside to the lab bench for research, and adapting (translating) discoveries in the lab into enhanced or new treatments at the patient’s bedside."
Funding also helps train young researchers by supporting students being mentored in the unit.
